Rheos Medicines
PrivateCompany Overview
Rheos Medicines operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. It was founded in 2018.
Rheos Medicines was a biopharmaceutical company that developed precision medicines for autoimmune and inflammatory diseases by targeting the metabolic pathways of immune cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rheos Medicines Comparables
Compare Rheos Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sitryx | 84% | |
| META Pharmaceuticals Inc. | 82% | |
| Immunai | 78% |
For institutional investors. Book with your work email.
Rheos Medicines Funding Rounds
Historical fundraising activity
Rheos Medicines Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rheos Medicines's valuation, stock price, and market status.
Is Rheos Medicines a public or private company?
Rheos Medicines is a private company.
What is the current stock price of Rheos Medicines?
Rheos Medicines is a private company, so its shares have no public market price. Caplight tracks Rheos Medicines's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rheos Medicines worth (valuation)?
Valuation information for Rheos Medicines is not publicly available.
Can I buy Rheos Medicines stock?
Rheos Medicines shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rheos Medicines's last funding round?
Funding round information for Rheos Medicines is not publicly available.
Who are the main investors in Rheos Medicines?
Investor information for Rheos Medicines is not publicly disclosed.
Will Rheos Medicines IPO soon?
No public IPO plans have been announced for Rheos Medicines.
How can I track Rheos Medicines secondary market activity?
Caplight tracks bids, offers, and trades in Rheos Medicines's shares on secondary markets.